Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.
Mol Oncol. 2022 Mar;16(6):1329-1346. doi: 10.1002/1878-0261.13192. Epub 2022 Feb 28.
Mol Oncol. 2022.
PMID: 35148461
Free PMC article.
Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma.
Kawakami I, Yoshino H, Fukumoto W, Tamai M, Okamura S, Osako Y, Sakaguchi T, Inoguchi S, Matsushita R, Yamada Y, Tatarano S, Nakagawa M, Enokida H.
Kawakami I, et al. Among authors: okamura s.
Biochem Biophys Res Commun. 2022 Jun 30;611:99-106. doi: 10.1016/j.bbrc.2022.04.068. Epub 2022 Apr 20.
Biochem Biophys Res Commun. 2022.
PMID: 35487063
Free article.
Item in Clipboard
Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor.
Yoshino H, Yokoyama S, Tamai M, Okamura S, Iizasa S, Sakaguchi T, Osako Y, Inoguchi S, Matsushita R, Yamada Y, Nakagawa M, Tatarano S, Tanimoto A, Enokida H.
Yoshino H, et al. Among authors: okamura s.
FEBS Open Bio. 2023 Jun;13(6):1056-1066. doi: 10.1002/2211-5463.13616. Epub 2023 Apr 29.
FEBS Open Bio. 2023.
PMID: 37079001
Free PMC article.
Item in Clipboard
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
Okamura S, Yoshino H, Kuroshima K, Tsuruda M, Osako Y, Sakaguchi T, Yonemori M, Yamada Y, Tatarano S, Nakagawa M, Enokida H.
Okamura S, et al.
BMC Cancer. 2021 Jan 11;21(1):48. doi: 10.1186/s12885-020-07717-0.
BMC Cancer. 2021.
PMID: 33430801
Free PMC article.
Item in Clipboard
Oncogenic effects of RAB27B through exosome independent function in renal cell carcinoma including sunitinib-resistant.
Tsuruda M, Yoshino H, Okamura S, Kuroshima K, Osako Y, Sakaguchi T, Sugita S, Tatarano S, Nakagawa M, Enokida H.
Tsuruda M, et al. Among authors: okamura s.
PLoS One. 2020 May 7;15(5):e0232545. doi: 10.1371/journal.pone.0232545. eCollection 2020.
PLoS One. 2020.
PMID: 32379831
Free PMC article.
Item in Clipboard
PKN1 kinase-negative knock-in mice develop splenomegaly and leukopenia at advanced age without obvious autoimmune-like phenotypes.
Siddique SM, Kubouchi K, Shinmichi Y, Sawada N, Sugiura R, Itoh Y, Uehara S, Nishimura K, Okamura S, Ohsaki H, Kamoshida S, Yamashita Y, Tamura S, Sonoki T, Matsuoka H, Itoh T, Mukai H.
Siddique SM, et al. Among authors: okamura s.
Sci Rep. 2019 Sep 27;9(1):13977. doi: 10.1038/s41598-019-50419-2.
Sci Rep. 2019.
PMID: 31562379
Free PMC article.
Item in Clipboard
Potential new therapy of Rapalink-1, a new generation mammalian target of rapamycin inhibitor, against sunitinib-resistant renal cell carcinoma.
Kuroshima K, Yoshino H, Okamura S, Tsuruda M, Osako Y, Sakaguchi T, Sugita S, Tatarano S, Nakagawa M, Enokida H.
Kuroshima K, et al. Among authors: okamura s.
Cancer Sci. 2020 May;111(5):1607-1618. doi: 10.1111/cas.14395. Epub 2020 May 5.
Cancer Sci. 2020.
PMID: 32232883
Free PMC article.
Item in Clipboard
Cite
Cite